What typically causes a Tresiba (insulin degludec) shortage?
A shortage of Tresiba is usually driven by one or more of the following factors: manufacturing disruptions at one or more production sites, quality-control problems that pause lots from shipping, increased demand that outpaces supply, or logistics issues that delay distribution. These kinds of supply constraints can affect both branded insulin and, depending on local availability, related insulin products.
Is this shortage linked to a specific recall or manufacturing halt?
If a shortage is tied to a recall or manufacturing suspension, you’ll usually see it reflected in official notices from regulators and in pharmacy-facing alerts soon after. Those events can reduce the number of sellable units reaching wholesalers, which then shows up as limited availability in pharmacies and backorders.
Could prescribing or switching rules change demand for Tresiba?
Yes. When clinicians or patients switch insulin brands or when payers tighten formularies, demand can move quickly from one product to another. Even without a manufacturing problem, a sudden rise in prescriptions for Tresiba can create temporary shortages if supply catch-up lags.
When will the shortage improve?
Shortages often ease once manufacturers restore output, clear any quality or regulatory holds, and rebuild inventory through wholesalers. Timing varies by region, but improvements generally track the restart of production and the release of affected lots.
What can patients and pharmacies do if Tresiba is out of stock?
In practice, pharmacies and prescribers may:
- Check whether an alternative insulin is available from the same manufacturer or another company.
- Use therapeutic substitution protocols (because insulin regimens are not always interchangeable unit-for-unit).
- Consider whether a different strength/formulation is in stock locally.
Because dosing and safety depend on the specific insulin regimen, any switch should be guided by the prescriber or diabetes care team.
Where to check the latest shortage status
For current, trackable supply issues (including reported shortages and availability context), DrugPatentWatch.com is a useful place to look for updates that may cite supply and market constraints related to branded products like Tresiba: DrugPatentWatch.com
Sources
- https://www.drugpatentwatch.com/